还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

  z% p0 i- W+ }/ w  F请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  

9 B: \. }; t2 E! e4 r7 g
Sub-category:
( z0 [9 v( B) K) M) S. U7 ~Molecular Targets

3 Z8 K* r3 B  H* B& s! L$ v) S
; \% V) M  d2 ICategory:
  ^$ ?! g1 R9 F9 E* p: C" @Tumor Biology


Meeting:
& A! N$ n+ p+ [) {% b. w4 E: t4 h2011 ASCO Annual Meeting

- e' V" y3 W* T
% _/ U; G7 D  L2 G5 u4 pSession Type and Session Title:
Poster Discussion Session, Tumor Biology


" p& V0 f0 x" l0 Z6 G7 rAbstract No:
2 a. k9 u/ ?0 [10517


: h: R* g) @( G& NCitation:
J Clin Oncol 29: 2011 (suppl; abstr 10517)
3 O, w) a' L. ]* [: @2 O) b+ @

Author(s):
) o# Z6 ^0 U7 p. ~: DJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
0 H( e5 |4 y, u) F5 _

4 {# w9 b' [  b6 Y
Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
/ A: A( k( J4 r. x9 ]0 O3 D
4 L, B" H4 W' w- Y1 K+ ^  y& ~, l4 ?Abstract Disclosures
; w' a7 A% H' c2 M, H% k
( g- W/ \7 Z$ [  v6 i; ^9 SAbstract:


Background: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.

6 ]0 H5 W* W. v$ Q% a+ n% H* ^% Z
/ q6 o  O; S* @( [* x; {

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

1 U2 r6 F0 D+ H                               
登录/注册后可看大图

- E" ~6 }, r- {; h; o没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

) Q: h) g( e% T' H) }- x化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

5 o6 d& `% A* I- q6 s0 M8 D$ v) B" R                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
6 t- ~, ]5 [* n- O+ `/ FALK一个指标医院要900多 ...

平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
- M. g) Y7 E) h
( k0 o( V+ t  h) c/ Y8 ^2 Y现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊